Skip to main content

Gastrointestinal Tract Infections

  • Chapter
  • First Online:
Management of Antimicrobials in Infectious Diseases

Part of the book series: Infectious Disease ((ID))

  • 1784 Accesses

Abstract

Gastrointestinal (GI) tract infections are caused by a wide variety of fungi, viruses, and bacteria, and all areas of the GI tract are affected. Infections range from mild, where disease is self-limited and supportive care is the treatment, to severe, where hospitalization and intravenous fluids and antibiotics are required for survival. In recent years, the increasing antibiotic resistance of various bacteria has become an important aspect of GI infection treatment and has resulted in augmentation of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vazquez JA (2000). Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials 1:47–59

    Article  PubMed  CAS  Google Scholar 

  2. Pace F, Pallotta S, Antinori S (2007). Nongastroesophageal reflux disease-related infectious, inflammatory, and injurious disorders of the esophagus. Curr Opin Gastroenterol 23:446–451

    PubMed  Google Scholar 

  3. Vazquez JA, Sobel JD (2002). Mucosal candidiasis. Infect Dis Clin N Am 16:793–820

    Article  Google Scholar 

  4. Krause DS, Simjee AE, Rensburg C et al. (2004). A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis 39:770–775

    Article  PubMed  CAS  Google Scholar 

  5. Makola D, Peura DA, Crowe SE (2007). Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 41(6):548–558

    Article  PubMed  Google Scholar 

  6. Goldberg D, Szilagyi A, Graves L (2007). Hyperemesis gravidarum and Helicobacter pylori infection. Obstet Gynecol 110:695–703

    Article  Google Scholar 

  7. Ramakrishnan K, Salinas R (2007). Peptic ulcer disease. Am Fam Physician 76:1005–1012

    PubMed  Google Scholar 

  8. Zagari RM, Bianchi-Porro G, Fiocca R et al. (2007). Comparison of 1 and 2 weeks of omeprazole, amoxicillin, and clarithromycin treatment for Helicobacter pylori eradication: The HYPER study. Gut 56:475–479

    Article  PubMed  CAS  Google Scholar 

  9. Zullo A, De Francesco V, Hassan C et al. (2007). The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis. Gut 56:1353–1357

    Article  PubMed  CAS  Google Scholar 

  10. Laesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL (2007). Helicobacter pylori and probiotics. J Nutr 137(3 Suppl 2):812S–818S

    Google Scholar 

  11. Penner R, Fedorak RN, Madsen KL (2005). Probiotics and nutraceuticals: Non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 5:596–603

    Article  PubMed  CAS  Google Scholar 

  12. Grimwood K, Buttery JP (2007). Clinical update: Rotavirus gastroenteritis and its prevention. Lancet 370:302–304

    Article  PubMed  Google Scholar 

  13. Vesikari T, Matson DO, Dennehy P et al. (2006). Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33

    Article  PubMed  CAS  Google Scholar 

  14. Estes MK, Prasad BV, Atmar RL (2006). Noroviruses everywhere: Has something changed? Curr Opin Infect Dis 19:467–474

    Article  PubMed  Google Scholar 

  15. CDC (2006). Norovirus: Technical fact sheet. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. (Accessed on Jul 15, 2008 http://www.cdc.gov/ncidod/dvrd/revb/gastro/noro-factsheet.pdf)

  16. Thielman NM, Guerrant RL (2004). Acute infectious diarrhea. N Engl J Med 350:38–47

    Article  PubMed  CAS  Google Scholar 

  17. Gadewar S, Fasano A (2005). Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharm 5:559–565

    Article  CAS  Google Scholar 

  18. Ilnyckyj A (2001). Clinical evaluation and management of acute infectious diarrhea in adults. Gastroenterol Clin N Am 30:599–609

    Article  CAS  Google Scholar 

  19. Marcos LA, DuPont HL (2007). Advances in defining etiology and new therapeutic approaches in acute diarrhea. J Infect 55:385–393

    Article  PubMed  Google Scholar 

  20. Yates J (2005). Traveler’s diarrhea. Am Fam Physician 71:2095–2100

    PubMed  Google Scholar 

  21. Shlim DR (2005). Update in traveler’s diarrhea. Infect Dis Clin N Am 19:137–149

    Article  Google Scholar 

  22. Panoz GZ, Betsi GI, Falagas ME (2006). Systematic review: Are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther 24:731–742

    Article  Google Scholar 

  23. Tarr PI, Gordon CA, Chandler WL (2005). Shiga-toxin-producing Escherichia coli and hemolytic uraemic syndrome. Lancet 365:1073–1086

    PubMed  CAS  Google Scholar 

  24. Todd WTA, Dundas S (2001). The management of VTEC O157 infection. Int J Food Microbiol 66:103–110

    Article  PubMed  CAS  Google Scholar 

  25. Qadri F, Svennerholm A, Faruque ASG, Sack RB (2005). Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 18:465–483

    Article  PubMed  Google Scholar 

  26. Galanis E (2007). Campylobacter and bacterial gastroenteritis. CMAJ 177:570–571

    Article  PubMed  Google Scholar 

  27. Gibreel A, Taylor DE (2006). Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 58:243–255

    Article  PubMed  CAS  Google Scholar 

  28. DuPont HL (2007). The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis 45:1352–1361

    Article  Google Scholar 

  29. Moore JE, Barton MD, Blair IS et al. (2006). The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 8:1955–1966

    Article  PubMed  CAS  Google Scholar 

  30. Linam WM, Gerber MA (2007). Changing epidemiology and prevention of Salmonella infections. Pediatr Infect Dis J 26:747–748

    Article  PubMed  Google Scholar 

  31. Hohmann EL (2001). Nontyphoidal salmonellosis. Clin Infect Dis 32:263–269

    Article  PubMed  CAS  Google Scholar 

  32. Graham SM (2002). Salmonellosis in children in developing and developed countries and populations. Curr Opin Infect Dis 15:507–512

    Article  PubMed  Google Scholar 

  33. Molbak K (2005). Human health consequences of antimicrobial drug–resistant Salmonella and other foodborne pathogens. Clin Infect Dis 41:1613–1620

    Article  PubMed  Google Scholar 

  34. Bhutta ZA (2006). Current concepts in the diagnosis and treatment of typhoid fever. BMJ 333:78–82

    Article  PubMed  Google Scholar 

  35. Luxemburger C, Dutta AK (2005). Overlapping epidemiologies of Hepatitis A and typhoid fever: The needs of the traveler. J Travel Med 12:S12–S21

    Article  PubMed  Google Scholar 

  36. Sur D, Ramamurthy T, Deen J, Bhattacharya SK (2004). Shigellosis: Challenges & management issues. Indian J Med Res 120:454–462

    PubMed  Google Scholar 

  37. Zuckerman JN, Rombo L, Fisch A (2007). The true burden and risk of cholera: Implications for prevention and control. Lancet Infect Dis 7:521–530

    Article  PubMed  Google Scholar 

  38. Sack DA, Sack RB, Nair GB et al. (2004). Cholera. Lancet 363:223–233

    Article  PubMed  CAS  Google Scholar 

  39. Griffith DC, Kelly-Hope LA, Miller MA (2006). Review of reported cholera outbreaks worldwide, 1995–2005. Am J Trop Med Hyg 75:973–977

    PubMed  Google Scholar 

  40. DeBerardis B, Torresini G, Brucchi M et al. (2004). Yersinia enterocolitica intestinal infection with ileum perforation: Report of a clinical observation. Acta Biomed 75:77–81

    Google Scholar 

  41. Fredriksson-Ahomaa M, Korkeala H (2003). Low occurrence of pathogenic Yersinia enterocolitica in clinical, food, and environmental samples: A methodological problem. Clin Microbiol Rev 6:220–229

    Article  Google Scholar 

  42. Skovgaard N (2007). New trends in emerging pathogens. Int J Food Microbiol 120:217–224

    Article  PubMed  Google Scholar 

  43. Bottone EJ (1997). Yersinia enterocolitica: The charisma continues. Clin Microbiol Rev 10:257–276

    PubMed  CAS  Google Scholar 

  44. Ehling-Schulz M, Fricker M, Scherer S (2004). Bacillus cereus, the causative agent of an emetic type of food-borne illness. Mol Nutr Food Res 48:479–487

    Article  PubMed  Google Scholar 

  45. Schlech WF (2003). Foodborne Listeriosis. Clin Infect Dis 31:770–775

    Article  Google Scholar 

  46. Swaminathan B, Gerner-Smidt P (2007). The epidemiology of human listeriosis. Microbes Infect 9:1236–1243

    Article  PubMed  Google Scholar 

  47. Razavi B, Apisarnthanarak A, Mundy LM (2007). Clostridium difficile: Emergence of hypervirulence and fluoroquinolone resistance. Infection 35:300–307

    Article  PubMed  CAS  Google Scholar 

  48. Crogan NL, Evans BC (2007). Clostridium difficile: An emerging epidemic in nursing homes. Geriatr Nurs 28:161–164

    Article  PubMed  Google Scholar 

  49. Kuijper EJ, van Dissel JT, Wilcox MH (2007). Clostridium difficile: Changing epidemiology and new treatment options. Curr Opin Infect Dis 20:376–383

    PubMed  Google Scholar 

  50. Miller MA (2007). Clinical management of Clostridium difficile-associated disease. Clin Infect Dis 45:S122–S128

    Article  PubMed  CAS  Google Scholar 

  51. Balagopal A, Sears CL (2007). Clostridium difficile: New therapeutic options. Curr Opin Pharm 7:455–458

    Article  CAS  Google Scholar 

  52. Vesy CJ, Peterson WL (1999). Review article: The management of giardiasis. Aliment Pharmacol Ther 13:843–850

    Article  PubMed  CAS  Google Scholar 

  53. Ali V, Nozaki T (2007). Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by “amitochondriate” protozoan parasites. Clin Microbiol Rev 20:164–187

    Article  PubMed  CAS  Google Scholar 

  54. Huang DB, White AC (2006). An updated review on Cryptosporidium and Giardia. Gastroenterol Clin N Am 35:291–314

    Article  Google Scholar 

  55. Dominguez EP, Sweeney JF, Choi YU (2006). Diagnosis and management of diverticulitis and appendicitis. Gastroenterol Clin N Am 35:367–391

    Article  Google Scholar 

  56. Jacobs DO (2007). Diverticulitis. N Engl J Med 357:2057–2066

    Article  PubMed  CAS  Google Scholar 

  57. Uronis HE, Bendell JC (2007). Anal cancer: An overview. Oncologist 12:524–534

    Article  PubMed  Google Scholar 

  58. Palefsky J (2006). Human papillomavirus-related tumors in HIV. Curr Opin Oncol 18:463–468

    Article  PubMed  Google Scholar 

  59. Stanley M (2007). Prophylactic HPV vaccines: Prospects for eliminating ano-genital cancer. Br J Cancer 96:1320–1323

    PubMed  CAS  Google Scholar 

  60. Andoh A, Fujiyama Y (2006). Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J Gastroenterol 12:4452–4460

    PubMed  Google Scholar 

  61. Perencevich M, Burakoff R (2006). Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 12:651–664

    Article  PubMed  Google Scholar 

  62. Gionchetti P, Rizzello F, Lammers KM et al. (2006). Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306–3313

    PubMed  CAS  Google Scholar 

  63. Hecht GA (2008). Inflammatory bowel disease – live transmission. N Engl J Med 358: 528–530

    Article  PubMed  CAS  Google Scholar 

  64. Kozuch PL, Hanauer SB (2008). Treatment of inflammatory bowel disease: A review of medical therapy. World J Gastroenterol 14:354–377

    Article  PubMed  CAS  Google Scholar 

  65. Brundage SC, Fitzpatrick AN (2006). Hepatitis A. Am Fam Physician 73:2162–2168

    PubMed  Google Scholar 

  66. Wilson TR (2005). The ABCs of hepatitis. Nurse Pract 30:12–21

    Article  PubMed  Google Scholar 

  67. Zuckerman JN (2006). Vaccination against hepatitis A and B: Developments, deployment, and delusions. Curr Opin Infect Dis 19:456–459

    Article  PubMed  CAS  Google Scholar 

  68. Lin KW, Kirchner JT (2004). Hepatitis B. Am Fam Physician 69:75–82, 86

    Google Scholar 

  69. Stribling R, Sussman N, Vierling JM (2006). Treatment of hepatitis C infection. Gastroenterol Clin N Am 35:463–486

    Article  Google Scholar 

  70. Brusaferro S, Barbone F, Andrian P et al. (1999). A study on the role of the family and other risk factors in HCV transmission. Eur J Epidemiol 15:125–132

    Article  PubMed  CAS  Google Scholar 

  71. Isaguliants MG (2007). Functionality of the immune system in patients with chronic hepatitis C: Trial by superinfections and vaccinations. Expert Rev Vaccines 6:527–537

    Article  PubMed  CAS  Google Scholar 

  72. Tan J, Lok ASF (2006). Update on viral hepatitis: 2006. Curr Opin Gastroenterol 23:263–267

    Article  Google Scholar 

  73. Rosenberg PM (2001). Hepatitis C: A hepatologist’s approach to an infectious disease. Clin Inf Dis 33:1728–1732

    Article  CAS  Google Scholar 

  74. Bacon BR, McHutchinson JG (2007). Into the light: Strategies for battling hepatitis C. Am J Manag Care 13:S319–S326

    PubMed  Google Scholar 

  75. Emerson SU, Purcell RH (2007). Hepatitis E. Pediatr Infect Dis J 26:1147–1148

    Article  PubMed  Google Scholar 

  76. Jaroszewicz J, Flisiak R, Kalinowska A et al. (2005). Acute hepatitis E complicated by acute pancreatitis: A case report and literature review. Pancreas 30:382–384

    Article  PubMed  Google Scholar 

  77. Kuiper JJ, van Buuren HR, de Man RA (2007). Ascites in cirrhosis: A review of management and complications. Neth J Med 65:283–288

    PubMed  CAS  Google Scholar 

  78. Heidelbaugh JJ, Sherbondy M (2006). Cirrhosis and chronic liver failure: Part II. Complications and treatment. Am Fam Physician 74:767–777

    PubMed  Google Scholar 

  79. Koulaouzidis A, Bhat S, Karagiannidis A et al. (2007). Spontaneous bacterial peritonitis. Postgrad Med J 83:379–383

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert E. Post .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Post, R.E., Hainer, B.L. (2010). Gastrointestinal Tract Infections. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-239-1_12

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-238-4

  • Online ISBN: 978-1-60327-239-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics